Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NITROGLYCERIN 0.2 MG/HR PATCH

nitroglycerin
$0.6132per EA

Strength

.2 mg/h

Manufacturer

Mylan Pharmaceuticals Inc.

NDC

00378910493

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

NITROGLYCERIN

Approval Type

Generic (ANDA)

FDA Application

ANDA074559

On Market Since

8/30/1996

Pharmacological Classes

Nitrate Vasodilator
Nitrates
Vasodilation

Price History

1W

0.0%

1M

+1.2%

3M

+1.7%

6M

+7.8%

1Y

+2.0%

3Y

+13.0%

5Y

+9.3%

All

+23.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

HYDRALAZINE 10 MG TABLET
Generic
00904744761•Major Pharmaceuticals
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
23155000101•Heritage Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
23155000110•Heritage Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
23155083201•Heritage Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
23155083210•Heritage Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
31722051901•Camber Pharmaceuticals Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50111039801•Teva Pharmaceuticals USA Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50111039803•Teva Pharmaceuticals USA Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50228018201•ScieGen Pharmaceuticals, Inc.
$0.0270
per EA
HYDRALAZINE 10 MG TABLET
Generic
50228018210•ScieGen Pharmaceuticals, Inc.
$0.0270
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy